[go: up one dir, main page]

MXPA99004343A - Process for the preparation of an oral pharmaceutical composition, oral pharmaceutical composition and equipment comprising said pharmaceutical composition. - Google Patents

Process for the preparation of an oral pharmaceutical composition, oral pharmaceutical composition and equipment comprising said pharmaceutical composition.

Info

Publication number
MXPA99004343A
MXPA99004343A MX9904343A MX9904343A MXPA99004343A MX PA99004343 A MXPA99004343 A MX PA99004343A MX 9904343 A MX9904343 A MX 9904343A MX 9904343 A MX9904343 A MX 9904343A MX PA99004343 A MXPA99004343 A MX PA99004343A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
oral pharmaceutical
preparation
antibiotic
equipment
Prior art date
Application number
MX9904343A
Other languages
Spanish (es)
Inventor
Martins Soares Angela
Original Assignee
Ind Quimica E Farmaceutica Sch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Quimica E Farmaceutica Sch filed Critical Ind Quimica E Farmaceutica Sch
Priority to MX9904343A priority Critical patent/MXPA99004343A/en
Publication of MXPA99004343A publication Critical patent/MXPA99004343A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention refers to a process for the preparation of an oral pharmaceutical composition comprising an antibiotic in the form of a powder that comprises the stages of mixture, low agitation, of the antibiotic active principle with one or more excipients composed of agglutinants, thickeners or moisteners together with at least a film former compound, drying and milling of the resulting mass; characteristic for the fact that the resultant granules possess a size in the varied range of 0,150 to 0,355mm. In another aspect, the invention refers to oral pharmaceutical compositions containing an antibiotic as a coated-granulated powder.
MX9904343A 1999-05-11 1999-05-11 Process for the preparation of an oral pharmaceutical composition, oral pharmaceutical composition and equipment comprising said pharmaceutical composition. MXPA99004343A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9904343A MXPA99004343A (en) 1999-05-11 1999-05-11 Process for the preparation of an oral pharmaceutical composition, oral pharmaceutical composition and equipment comprising said pharmaceutical composition.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9904343A MXPA99004343A (en) 1999-05-11 1999-05-11 Process for the preparation of an oral pharmaceutical composition, oral pharmaceutical composition and equipment comprising said pharmaceutical composition.

Publications (1)

Publication Number Publication Date
MXPA99004343A true MXPA99004343A (en) 2004-08-27

Family

ID=35985134

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9904343A MXPA99004343A (en) 1999-05-11 1999-05-11 Process for the preparation of an oral pharmaceutical composition, oral pharmaceutical composition and equipment comprising said pharmaceutical composition.

Country Status (1)

Country Link
MX (1) MXPA99004343A (en)

Similar Documents

Publication Publication Date Title
YU57600A (en) Bicyclic hydroxamic acid derivatives
AU2001236207A1 (en) Powder formulation
IL144361A0 (en) Gcsf conjugates
AU3912493A (en) A pharmaceutical composition containing a defined lipid system
AU5677099A (en) New solid dose form of nanoparticulate naproxen
CA2338358A1 (en) Compounds and compositions for delivering active agents
BR0003158A (en) Instant melting oral dosage formulation
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
CZ2001449A3 (en) Compounds and compositions for delivering active agents
MX9603314A (en) Compositions containing micronized nebivolol.
BG103947A (en) Derivatives of 9-oxymerythromycin
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
CA2318260A1 (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
YU59400A (en) Azabicyclic 5ht1 receptor ligands
PH31395A (en) Bis-naphthalimides for the treatment of cancer.
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
AP2000001837A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs.
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
IS6919A (en) Continuous pharmaceutical composition comprising torsemide variant II
MXPA99004343A (en) Process for the preparation of an oral pharmaceutical composition, oral pharmaceutical composition and equipment comprising said pharmaceutical composition.
WO2002011740A3 (en) 'slow release' pharmaceutical compositions comprising lithium carbonate
MXPA04006005A (en) Ultrapure oral fludara formulation with a fast releasing active substance.
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
AU8452791A (en) 1-phenyl-3-aryl-2-propyne-1-ones
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses